# SECURITIES AND
EXCHANGE COMMISSIONWashington, D.C. 20549

_________________

FORM 8-K

# Current report
Pursuant to Section 13 or 15(d) ofthe Securities
Exchange Act of 1934

# Date of report (Date
of earliest event reported): November 25, 2003

DOTRONIX, INC.(Exact name of
registrant as specified in its charter)

|Minnesota                    | 0-9996       | 41-1387074         
|---------------------------- | ------------ | -------------------
|(State or other jurisdiction | (Commission  | (I.R.S. Employer   
|of incorporation)            | File Number) | Identification No.)

|160 First Street S.E., New Brighton, Minnesota | 55112-7894
|---------------------------------------------- | ----------
|(Address of principal executive offices)       | (Zip Code)

Registrant's telephone number,
including area code:  (651) 633-1742

N/A
(Former name
or former address, if changed since last report.)



---

|Item 7. |  | Financial
Statements and Exhibits.
|------- |  | ----------------------------------

| | (a) |  | Financial
statements: None.
| | --- |  | ---------------------------

| | (b) |  | Pro
forma financial information: None.
| | --- |  | --------------------------------------

| | (c) |  | Exhibits:
| | --- |  | ---------

| |  |  | Exhibit 99.1 |  | Press
release dated November 25, 2003 with respect to results for quarter and year endedJune
30, 2003
| |  |  | ------------ |  | -----------------------------------------------------------------------------------------------------

| |  |  | Exhibit 99.2 |  | Press
release dated November 25, 2003 with respect to results for quarter ended September 30,
2003
| |  |  | ------------ |  | --------------------------------------------------------------------------------------------------

|Item 12. |  | Disclosure
of Results of Operations and Financial Condition.
|-------- |  | ------------------------------------------------------------

On
November 25, 2003, Dotronix, Inc. issued press releases announcing the (i) results for
the quarter and year ended June 30, 2003 and (ii) results for the quarter ended September
30, 2003. The full text of the press releases are set forth in Exhibits 99.1 and 99.2
attached hereto and are incorporated in this Current Report as if fully set forth herein.

The information in this Form 8-K
shall not be deemed filed for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that
Section. The information in the Current Report shall not be incorporated by reference
into any registration statement pursuant to the Securities Act of 1933, as amended.

SIGNATURES

Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.

|                         | Dotronix, Inc.                                                                                                        
|------------------------ | ----------------------------------------------------------------------------------------------------------------------
|Date:  November 25, 2003 | By:/s/ Robert V. Kling                                                                                                
|                         | Robert V. Kling
                                                                               Chief Financial Officer